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Abstract. 
 
In contrast to terminally differentiated car-
diomyocytes, relatively little is known about the charac-
teristics of mammalian cardiac cells before the initia-
tion of spontaneous contractions (precursor cells). 
Functional studies on these cells have so far been im-
possible because murine embryos of the corresponding 
stage are very small, and cardiac precursor cells cannot 
be identified because of the lack of cross striation and 
spontaneous contractions.
In the present study, we have used the murine embry-
onic stem (ES, D3 cell line) cell system for the in vitro 
differentiation of cardiomyocytes. To identify the car-
diac precursor cells, we have generated stably trans-
fected ES cells with a vector containing the gene of the 
green fluorescent protein (GFP) under control of the 
cardiac 
 
a
 
-actin promoter. First, fluorescent areas in ES 
cellÐderived cell aggregates (embryoid bodies [EBs]) 
were detected 2 d before the initiation of contractions. 
 
Since Ca
 
2
 
1
 
 homeostasis plays a key role in cardiac func-
tion, we investigated how Ca
 
2
 
1
 
 channels and Ca
 
2
 
1
 
 re-
lease sites were built up in these GFP-labeled cardiac 
precursor cells and early stage cardiomyocytes. Patch 
clamp and Ca
 
2
 
1
 
 imaging experiments proved the func-
tional expression of the L-type Ca
 
2
 
1
 
 current (I
 
Ca
 
) start-
ing from day 7 of EB development. On day 7, using 10 
mM Ca
 
2
 
1
 
 as charge carrier, I
 
Ca
 
 was expressed at very 
low densities 4 pA/pF. The biophysical and pharmaco-
logical properties of I
 
Ca
 
 proved similar to terminally 
differentiated cardiomyocytes. In cardiac precursor 
cells, I
 
Ca
 
 was found to be already under control of 
cAMP-dependent phosphorylation since intracellular 
infusion of the catalytic subunit of protein kinase A re-
sulted in a 1.7-fold stimulation. The adenylyl cyclase ac-
tivator forskolin was without effect. IP
 
3
 
-sensitive intra-
cellular Ca
 
2
 
1
 
 stores and Ca
 
2
 
1
 
-ATPases are present 
during all stages of differentiation in both GFP-positive 
and GFP-negative cells. Functional ryanodine-sensitive 
Ca
 
2
 
1
 
 stores, detected by caffeine-induced Ca
 
2
 
1
 
 release, 
appeared in most GFP-positive cells 1Ð2 d after I
 
Ca
 
. Co-
expression of both I
 
Ca
 
 and ryanodine-sensitive Ca
 
2
 
1
 
 
stores at day 10 of development coincided with the be-
ginning of spontaneous contractions in most EBs.
Thus, the functional expression of voltage-dependent 
L-type Ca
 
2
 
1
 
 channel (VDCC) is a hallmark of early 
cardiomyogenesis, whereas IP
 
3
 
 receptors and sarcoplas-
mic Ca
 
2
 
1
 
-ATPases are expressed before the initiation 
of cardiomyogenesis. Interestingly, the functional ex-
pression of ryanodine receptors/sensitive stores is de-
layed as compared with VDCC.
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a
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T
 
he
 
 heart is the first organ to be formed during mu-
rine embryonic development. Between E7.5 and
E8, the generation of a single heart tube is initiated,
and from E8.5 to E9 the first contractions of this primitive
structure are observed (Fishman and Chien, 1997). While
 
the heart undergoes further changes during later stages of
development, essential components responsible for the
initiation of regular contractile activity are already estab-
lished at this early stage. Indeed, the first transcripts of
sarcomeric contractile proteins are already detectable on
E7.5 (Sassoon et al., 1988; Sanchez et al., 1991). There is
only sparse knowledge of the sequential expression of ion
channels and Ca
 
2
 
1
 
 release stores, both playing a funda-
mental role in cardiac function at these initial stages of de-
velopment. For terminally differentiated cardiomyocytes,
it is well established that voltage-dependent L-type Ca
 
2
 
1
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channels (VDCC)
 
1
 
 are responsible for transmembrane
Ca
 
2
 
1
 
 influx which secondarily leads to Ca
 
2
 
1
 
 induced Ca
 
2
 
1
 
release (CICR) (Fabiato, 1985; du Bell and Houser, 1987;
Barcenas-Ruiz and Wier, 1987; Nabauer et al., 1989) from
the sarcoplasmatic reticulum (SR) through ryanodine sen-
sitive Ca
 
2
 
1
 
 stores (Meissner, 1994). The calcium-induced
calcium release (CICR)-mediated increase of the free cy-
tosolic Ca
 
2
 
1
 
 concentration ([Ca
 
2
 
1
 
]
 
i
 
) is a prerequisite for
cardiac contraction. Increased [Ca
 
2
 
1
 
]
 
i
 
 is lowered by re-
uptake via the thapsigargin (Tg)-sensitive sarcoplasmic
Ca
 
2
 
1
 
-ATPase and extrusion via the Na
 
1
 
-Ca
 
2
 
1
 
 exchanger
as well as the sarcolemmal Ca
 
2
 
1
 
-ATPase (Bers, 1997).
Even though changes in the regulation of VDCC during
cardiac development have been reported for E11Ð13 mu-
rine cardiomyocytes (Davies et al., 1996), as well as for the
perinatal stage (Tohse et al., 1992
 
a
 
,
 
b
 
; Masuda et al., 1995)
and ES cellÐderived cardiomyocytes (Maltsev et al., 1994),
when and how cardiomyocytes differentiating from the
mesodermal lineage establish intracellular Ca
 
2
 
1
 
 stores
and the regulation of VDCC remains obscure. The latter
mechanism plays a key role in the adult heart for the con-
trol by the autonomic nervous system (Osterrieder et al.,
1982; Reuter, 1983; Hartzell and Fischmeister, 1986; Traut-
wein and Hescheler, 1990).
The aim of the present study was to investigate the ex-
pression and regulation of VDCC as well as of the estab-
lishment of Ca
 
2
 
1
 
 release channels in single cardiomyocytes
before the initiation of spontaneous contractions (cardiac
precursor cells). Studies on these early stage cells from
murine embryos have not been performed so far because
the heart is very small at this stage, and isolation proce-
dures have proved impossible before stage E11 (An et al.,
1996; Davies et al., 1996).
In the past, we have used embryonic stem (ES) cells for
the in vitro differentiation and isolation of cardiomyocytes
to circumvent this problem (Wobus et al., 1991; Maltsev
et al., 1994). However, at the very early stages of develop-
ment, cardiomyocytes cannot be recognized even in vitro
because of the lack of cross striation and beating (Davies
et al., 1996; Hescheler et al., 1997). To identify these car-
diac precursor cells, we have established ES cell clones sta-
bly transfected with the gene of the jellyfish 
 
Aequorea vic-
toria
 
 green fluorescent protein (GFP) (Prasher et al., 1992;
Chalfie et al., 1994) under control of a cardiac-specific pro-
moter. Since transcripts of 
 
a
 
-actin are among the earliest
detectable in the developing heart (Sassoon et al., 1988;
Lyons et al., 1991), and its expression was shown to be car-
diac specific in the ES cell system before the initiation of
spontaneous contractions (Metzger et al., 1996), we have
chosen the cardiac 
 
a
 
-actin promoter to drive the GFP ex-
pression. Based on a well-established protocol (Doetsch-
man et al., 1985; Wobus et al., 1991; Metzger et al., 1995),
ES cells were differentiated into cell aggregates (embryoid
bodies [EBs]) containing cardiomyocytes. The first spon-
taneously beating areas are noticed in 9-d-old EBs. In 15Ð
18-d-old EBs, terminally differentiated cardiomyocytes
are detected with almost identical morphological and elec-
trophysiological features as murine perinatal cardiomyo-
cytes (Hescheler et al., 1997).
Taking advantage of the tissue-specific GFP expression
in ES cellÐderived cardiomyocytes, we here describe the
functional characterization of cardiac precursor cells with
patch clamp and Ca
 
2
 
1
 
 imaging techniques. We demonstrate
that VDCC are already expressed at very low density in
7-d-old cardiac precursor cells and stimulated via cAMP-
dependent protein kinase A (PKA)-dependent phosphor-
ylation. However, the functional expression of ryanodine-
sensitive Ca
 
2
 
1
 
 receptors/stores was delayed in most cells
compared with VDCC, and their coexpression coincided
with the onset of spontaneous contractions.
 
Materials and Methods
 
Vectors
 
The pCX-EGFP expression vector containing the enhanced version of the
GFP coding sequence EGFP (CLONTECH Laboratories, Palo Alto, CA)
under the chicken 
 
b
 
-actin promoter (Ikawa et al., 1995; Okabe et al.,
1997) was provided by Dr. Okabe (University of Osaka, Japan) and modi-
fied as follows: The vector pPv/B-Act-lacZ containing the (
 
2
 
440 to 
 
1
 
6)
segment of the human cardiac 
 
a
 
-actin promoter (Minty and Kedes, 1986;
Pari et al., 1991) was provided by Dr. M.W. McBurney (University of Ot-
tawa, Canada). The promoter was excised from pPv/B-Act-lacZ by SalI
and HindIII restriction enzymes. The pCX-EGFP was digested with
SnaBI and ApaI restrictases to excise the chicken 
 
b
 
-actin promoter, which
was replaced by the above mentioned SalI-HindIII fragment of the car-
diac 
 
a
 
-actin promoter by blunt-end ligation. Then, SalI-XbaI restriction
fragment containing the Neomycin (G418) resistance gene from pTL2
Neo
 
R
 
 (provided by Dr. Tarakhovsky, Institute for Genetics, Cologne,
Germany) was inserted by blunt-end ligation in the SalI site of pCX-
EGFP. The resulting vector pCX-(
 
a
 
-act)-EGFP-Neo
 
R
 
 was used for
electroporation of ES cells of the line D3. ES cells were cultured on fibro-
blast feeder layers in DME supplemented with 15% FCS (GIBCO BRL;
Life Technologies, Gaithersburg, MD), 1
 
3
 
 nonessential amino acids
(GIBCO BRL) and 0.1 mM 
 
b
 
-mercaptoethanol (Sigma Chemical Co.,
St. Louis, MO).
 
Electroporation and Selection Procedure
 
pCX-(
 
a
 
-act)-EGFP-Neo
 
R
 
 was linearized by AatII restrictase to linearize
the vector and destroy the CMV-enhancer. Electroporation and G418 se-
lection was performed according to standard protocols. The pCX-(
 
a
 
-act)-
EGFP-Neo
 
R
 
Ðtransfected ES clones with GFP fluorescence comparable to
wild-type ES cells were selected using FACS
 
¨
 
 and used for the differenti-
ation protocol. EBs were generated using standard protocols as previously
described (Wobus et al., 1991). In brief, hanging drops were established by
plating a suspension of ES cells in final concentration of 0.020Ð0.025 
 
3 
 
10
 
6
 
cells/ml in 20 
 
m
 
l (400Ð500 cells) of DME 
 
1
 
 20% FCS on the lids of bacte-
rial dishes. After incubation at 37
 
8
 
C, 5% CO
 
2
 
 for 2 d, the growing EBs
were washed out with 10 ml DME 
 
1 
 
20% FCS into bacterial dishes and
incubated for an additional 4 d. Then, EBs were plated separately on gel-
atine-pretreated 24-well plates. During all stages of development, growing
EBs were monitored under the fluorescent microscope using an FITC fil-
ter set (Zeiss, Jena, Germany).
Since the investigated clones were selected using G418, their character-
istics may differ from wild-type ES cells. For this reason, several clones
(A1, A10, A12, and A17) were tested. No difference between selected
clones and parental cell line in regard to differentiation and initiation of
spontaneous contractions was noticed.
 
FACS
 
¨
 
For FACS
 
¨
 
 analysis, 10Ð20 EBs of different stages of development were
washed with PBS and then dissociated to a single cell suspension by
trypsin treatment for 2Ð3 min (120 
 
m
 
l of trypsin/EDTA solution). Then, 1 ml
of DME 
 
1
 
 20% FCS was added to the single-cell suspension. After cen-
trifugation (1,000 rpm) for 5 min, the cells were resuspended in 0.5Ð1.0 ml
of PBS containing Ca
 
2
 
1
 
 (1 mM) and Mg
 
2
 
1
 
 (0.5 mM).
 
1. 
 
Abbreviations used in this paper:
 
 ANP, atrial natriuretic peptide; CICR,
calcium-induced calcium release; DAB, 3,3-diaminobenzidine-tetrahydro-
chloride; EB, embryoid body; ES, embryonic stem; GFP, green fluorescent
protein; PKA, cAMP-dependent protein kinase A; SR, sarcoplasmic retic-
ulum; Tg, thapsigargin; VDCC, voltage-dependent L-type Ca
 
2
 
1
 
 channels. 
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The GFP expression by ES cellÐderived cells of different age was ana-
lyzed on a FACSCaliburª flow cytometer (Becton Dickinson) equipped
with a 488-nm argon-ion laser (15 mW). Cells were resuspended to a con-
centration of 5 
 
3 
 
10
 
5
 
 cells/ml in PBS (pH 7.0, 0.1% BSA) and then ana-
lyzed on the FACSCaliburª with a minimum of 10,000 viable cells ac-
quired for each sample. The emitted fluorescence of GFP was measured
at 530 nm (FITC band pass filter). Live gating was done by addition of
propidium iodide (2 
 
m
 
g/ml) to the samples immediately before measure-
ment. Necrotic cells with a positive propidium iodide staining (585-nm
band pass filter) showed higher side scattering signals compared with the
viable PI-negative cells. Nonviable cells were excluded from the subse-
quent analysis by gating on cells with low SSC signals. Nontransfected ES
cells of the cell line D3 were used for negative controls. Analyses were
performed using CellQuest
 
¨
 
 software (Becton Dickinson).
 
Dissociation of EBs and Preparation of
Single Cardiomyocytes
 
For the experiments using single cells, whole EBs, or for the later stages,
beating areas of 20Ð30 EBs were dissected and isolated by enzymatic dis-
persion, using collagenase B (Boehringer, Ingelheim, Germany), as de-
scribed in more detail by Maltsev et al. (1994). The solution used for the
dissociation of the dissected areas was the following (in mmol/L): 120
NaCl, 5.4 KCl, 5 MgSO
 
4
 
, 0.03 CaCl
 
2
 
, 5 Na pyruvate, 20 glucose, 20 taurine,
10 Hepes, and 0.5Ð1 mg/ml collagenase B, pH 6.9 (NaOH). The dissoci-
ated material was plated onto gelatine-coated glass coverslips and put into
the incubator in 20% FCS containing DME.
 
Immunocytochemistry
 
Single, enzymatically dissociated ES cellÐderived cells (11Ð14 d) were
plated on gelatin-covered glass coverslips overnight. Cells were subse-
quently fixed in a solution containing 4% paraformaldehyde in 0.1 M PBS
buffer, pH 7.4, for 15 min. After fixation, single-cell preparations were
washed several times in 0.1 M PBS and further treated with 0.1% Triton
X-100 (Sigma, Deisenhofen, Germany) in PBS-A (PBS containing 0.2%
acide, 0.01 glycine, and 0.002% Triton X-100). The following primary anti-
bodies were used: mouse monoclonal antiÐ
 
a
 
-actinin (sarcomeric), mouse
monoclonal antiÐ
 
a
 
-sarcomeric actin (Sigma), and rabbit polyclonal antiÐ
atrial natriuretic peptide (ANP; Biotrend, Kln, Germany). The second-
ary antibodies used were biotinylated goat antiÐmouse (Vector Laborato-
ries, Inc., Burlingame, CA), Cy3-labeled extravidin (Sigma), Cy3-labeled
purified goat antiÐrabbit IgG (Rockland Immunochemicals, Gilbertville,
PA), and streptavidinÐhorseradish peroxidase conjugate (Amersham In-
ternational, Buckinghamshire, UK). After BSA block (5% BSA in PBS),
cells were treated with murine primary antibodies to 
 
a
 
-actin diluted 1:800
or to 
 
a
 
-actinin diluted 1:600 in 0.8% BSA/PBS buffer at 4
 
8
 
C overnight.
Thereafter, cells were treated with a biotinylated IgG goat antiÐmouse an-
tibody at the dilution indicated by the manufacturer. Fluorescence label-
ing was performed with extravidin Cy3 diluted 1:600. For ANP detection,
single cells were treated with ANP antibody at 4
 
8
 
C overnight in a dilution
of 1:500 followed by treatment with anti-rabbit antibody (1:800) for 1 h at
room temperature. Single-cell preparations were observed through filter
set 10 (Zeiss; excitation BP 45Ð490, emission BP 515Ð565), which allows
recognition of GFP fluorescence, and filter set 15 (Zeiss; excitation BP
546/12, emission LP 590) for recognition of Cy3-labeled cells. Alter-
natively, for some experiments a streptavidinÐhorseradish peroxidase
complex was used as detection system (1:200 incubation for 1 h at room
temperature). The staining was developed for 15 min with 3,3-diami-
nobenzidine-tetrahydrochloride (DAB) in 5 mM Tris-HCl buffer, pH 7.4,
supplemented with 0.1% H
 
2
 
O
 
2
 
. Analysis was performed using an Axio-
phot microscope (Zeiss).
 
Ca
 
2
 
1
 
 Imaging Experiments
 
Monochromic excitation light (340, 380, and 488 nm) was generated by a
computer-controlled monochromator (TIL Photonics, Planegg, Germany)
and coupled to the epifluorescence attachment of an inverted microscope
(model 135M; Zeiss) through a small quartz light guide. The excitation
light was directed to the oil immersion objective (40
 
3
 
; Zeiss) via a fura-2
(TIL Photonics) or a FITC filter block (AHF, Tbingen, Germany). The
emitted fluorescence was imaged through a 470/525-nm interference filter
using an intensified charge coupled device camera (Thetha, Mnchen,
Germany) connected to the TV port of the microscope. Fluorescence im-
ages (50Ð100-ms exposure time) were acquired at a rate of 0.33 Hz using
the Fucal fluorescence software package (TIL Photonics). The analysis
was done off-line using the Fucal software package. Paired 340/380 images
within cursor defined areas of interest were background subtracted and
displayed as ratio images. These were converted into [Ca
 
2
 
1
 
]
 
i
 
 using the
equation of Grynkiewicz et al. (1985). In situ calibration factors, 
 
R
 
max 
 
ob-
tained in the presence of ionomycin and 10 mM Ca
 
2
 
1
 
 and R
 
min
 
 in the pres-
ence of excess EGTA, were determined in a series of experiments, and
these average values were used to calculate [Ca
 
2
 
1
 
]
 
i
 
. The values used for
 
R
 
max
 
, 
 
R
 
min
 
, and F380
 
max
 
/F380min were 4.3, 0.44, and 3.94 for ES cells, 2.18,
0.33, and 3.57 for EBs, and the dissociation constant was assumed to be
224. For the estimation of the GFP fluorescence intensity, the whole area
of the cell was integrated, and average fluorescence intensities were deter-
mined in counts. GFP fluorescence produced only minimal interference in
fura-2AMÐloaded cells. The composition of the recording solutions used
was the following (in mM): 135 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 5 Hepes, 10
glucose, pH 7.4 (NaOH). For the high K1 solution, the composition was
135 KCL, 5 NaCl, 2 MgCl2, 2 CaCl2, 5 Hepes, 10 glucose, pH 7.4 (KOH).
For some experiments, the following solution was used: 70 KCL, 70 NaCl,
2 MgCl2, 2 CaCl2, 5 Hepes, 10 glucose, pH 7.4 (KOH). High K1 solution
was perfused into the chamber, providing a complete exchange in less
than 20 s. Tg was bath added, and caffeine was applied through a puffer
pipette (General Valve, Fairfield, MA). All experiments were performed
at 378C.
Patch Clamp Recordings of ICa
Standard whole-cell recording techniques (Hamill et al., 1981) were used
(model Axopatch 200A amplifier; Axon Instruments, Foster City, CA).
Data were acquired using the Iso2 software package (MFK, Niedern-
hausen, Germany), sampled at 2 kHz and stored on hard disk. All patch
clamp experiments were performed at room temperature. Pipettes were
made on a DMZ Universal Puller (Mnchen, Germany) from 1.5-mm
borosilicate glass capillaries (Clark Electromedical Instruments, Reading,
UK). The compositions of the different recording solutions used were (in
mM) extracellular solution: 135 NaCl, 5 KCl, 10 CaCl2, 2 MgCl2, 5 Hepes,
10 glucose, pH 7.4 (NaOH); and pipette solution: 55 CsCl, 80 Cs2SO4, 2
MgCl2, 10 Hepes, 10 EGTA, 1 CaCl2, 5 ATP (Mg), pH 7.4 (CsOH).
ICa was evoked by 50-ms depolarizing voltage steps from a holding po-
tential of 280 mV to a step potential of 10 mV at a frequency of 0.2 Hz.
CurrentÐvoltage relationships were obtained by stepping from a holding
potential of 280 mV to step potentials between 240 mV to 140 mV in 10-
mV intervals. Pharmacological agents were applied through an applica-
tion pipette.
Experiments Using Intracellular Dialysis of IP3
For the investigation of IP3-sensitive Ca21 stores, pipettes were filled with
the following solution (in mM): 135 CsCl, 10 MgCl2, 10 Hepes, 0.015
EGTA, 0.125 Fura-2 acid, 0.1 IP3, pH 7.2 (CsOH) (see also Parekh et al.,
1997). After obtaining a gigaohm-seal, the cell of interest was perfused lo-
cally with nominally Ca21-free extracellular solution. Imaging at excita-
tion wavelengths of 360/390 nm was started at a rate of 4 Hz, and the clas-
sic whole-cell configuration was established (HP 5 280 mV). The analysis
of changes of [Ca21]i was performed as described in the imaging section.
When IP3 was omitted from the intracellular solution, no increase in 360/
390 ratio was observed.
Test Substances
IP3 (Calbiochem, Bad Soden, Germany) and the catalytic subunit of pro-
tein kinase A (Promega, Heidelberg, Germany) were dissolved in water
and frozen at 2208C. Tg (Molecular Probes, Leiden, The Netherlands)
was dissolved in DMSO, Nisoldipine (Bayer, Leverkusen, Germany), and
BayK8644 (Bayer) were dissolved in 30% ethanol. All remaining sub-
stances were obtained from Sigma. Stock solutions were prepared fresh or
defrozen before use and diluted in extracellular solution or culture me-
dium to the final concentration for superfusion of the recording chamber
(patch clamp) or added to the bath. The final concentration of the solvent
was below 0.05%. Averaged data are expressed as mean 6 SEM.
Results
Establishment and Specificity of the Cardiac a-Actin 
PromoterÐdriven GFP Expression and Identification of 
Cardiac Precursor Cells
First, we investigated whether GFP could be stably ex-The Journal of Cell Biology, Volume 143, 1998 2048
pressed in ES cells under control of the a-actin promoter
and what pattern of GFP expression could be observed
during differentiation The pCX-(a-act)-EGFP-NeoRÐtrans-
fected ES cells as well as EBs before plating (Fig. 1, A and
B) displayed only weak fluorescence under microscopic
observation. However, at the 7-d stage, i.e., 1 d after plat-
ing, areas with distinct fluorescence could be detected
(data not shown). Most of these GFP-positive areas devel-
oped 48Ð72 h later into spontaneously contracting regions
(Fig 1, C and D). During all stages of cardiomyogenesis,
strong fluorescence was exclusively detected in these beat-
ing areas (Fig. 1, C and D). This overlap between GFP ex-
pression and beating clearly indicated the cardiac specific-
ity of the human cardiac a-actin promoter.
The microscopic pattern of GFP expression was quanti-
tatively assessed using FACS¨. The profile of pCX-(a-act)-
EGFP-NeoRÐtransfected ES cells confirmed low fluores-
cence intensities at the ES cell stage (Fig. 2 B) comparable
to nontransfected wild-type ES cells (Fig. 2 A). During EB
development, an enlargement of the initial peak to higher
fluorescence intensities was observed. In some clones, par-
ticularly with low initial fluorescence (Fig. 2 B, 0d), the ap-
pearance of a second peak corresponding to GFP-express-
ing cells was noticed (Fig. 2 B, 7d and 12d). In 7-d-old EBs,
the fraction of GFP-positive cells amounted to 30Ð50% of
the whole EB. The FACS¨ profile of EBs containing clus-
ters of spontaneously contracting cardiomyocytes showed
a further broadening of the fluorescent peak to higher flu-
orescence intensities (Fig. 2 B, 12d), possibly correspond-
ing to the contracting cardiomyocytes. This was corrobo-
rated by measuring GFP fluorescence intensities of single
cells isolated from EBs at different stages of development.
Very low fluorescence levels were detected in 0Ð4-d-old
cells, but a clear increase and diversification of the GFP
fluorescence intensity was observed in cells from 8 d and
more prominently from 10-d-old EBs. The highest fluores-
cence intensities were detected in spontaneously beating
cardiomyocytes (data not shown).
The specificity of the GFP expression in pCX-(a-act)-
EGFP-NeoRÐtransfected ES cells was further corrobo-
rated by immunocytochemistry on single ES cellÐderived
cells. GFP expression under the a-cardiac actin promoter
proved to be tightly correlated with a-actin antibody stain-
ing (Fig. 3, A and B). Almost all (95%) of the GFP-posi-
tive cells (11 and 14 d) showed a-actin costaining (n 5
343). Furthermore, the GFP-positive cells displayed mor-
phological features typical for cardiomyocytes. Early stage
cardiomyoctes were small and round and showed a homo-
geneous distribution of myofilament specific proteins (Fig.
3, A and B) (Hescheler et al., 1997). Late-stage cardiomyo-
cytes were elongated with a typical pattern of condensed
a-actinin, indicating the development of sarcomeres. In
the late-stage cells, 93% of the GFP-expressing cells were
a-actinin positive (Fig. 3, C and D; n 5 96, 11Ð14 d).
Since 7-d-old GFP-positive cells had low a-actin content
and did not yet display morphological features typical for
cardiomyocytes, the more sensitive DAB method for im-
munostaining was used. 32% of 7-d-old cells were DAB
positive (n 5 191), whereas only 3.7% of DAB-positive
cells (n 5 161) were detected in undifferentiated D3 cells.
This percentage of a-actinÐcontaining cells corresponded
well with the fraction of GFP-positive cells revealed with
FACS¨ in 7-d-old EBs. To confirm further that GFP-posi-
tive cells (7Ð9 d) were indeed cardiac precursor cells stain-
ing with ANP, known to be expressed at early stages of
cardiomyogenesis but not skeletal myogenesis (Miller-
Hance et al., 1993; Hescheler et al., 1997), was performed.
All GFP-positive cells were ANP positive (data not shown),
unequivocally proving their cardiac nature.
VDCC Are Expressed in a-Actin PromoterÐdriven 
GFP-positive Cardiac Precursor Cells and Upregulated 
by Protein Kinase A
Initially, electrophysiological experiments were performed
on several GFP-positive clones (A1, A10, and A17), and
Figure 1. GFP expression under control of
the human cardiac a-actin promoter dur-
ing differentiation of ES cells. ES cells
were electroporated with the pCX-(a-act)-
EGFP-NeoR vector. (A and B) 5-d-old
EBs (clone E4) in suspension displayed
low GFP fluorescence (B). (C and D) 3 d
after plating (9-d-old EB), only spontane-
ously beating areas showed strong GFP
fluorescence. (A) Transmission light. (B
and  D) Fluorescence acquired with an
FITC filter block. (C) Combined fluores-
cence and transmission light. Bar, 200 mm.Kolossov et al. Functional Characteristics of Cardiac Precursor Cells 2049
no difference in their characteristics between the parental
ES cell line D3 and the different clones were noticed. For
the functional investigation of GFP-positive cells pre-
sented in this study, cell clones (A1 and A17) were chosen
in which the fluorescence of ES cells was comparable to
wild-type ES cells but at later stages developed a second
fluorescent peak observed with FACS¨. These clones al-
lowed the easy detection of GFP-positive cells already at
the cardiac precursor stage. All EBs used for the isolation
of single cells before 9 d of differentiation did not contain
contracting areas.
First, we investigated at which time point ICa becomes
functionally active during very early cardiac development.
Single-cell Ca21 imaging was performed, using the cell
membraneÐpermeant Ca21 indicator fura-2AM. From all
cells within the visual field GFP fluorescence was deter-
mined, thereafter [Ca21]i was monitored. GFP-positive
and -negative cells were characterized by stable resting
[Ca21]i of 92.7 6 10.5 nM (n 5 10) and of 91.7 6 9.8 nM (n 5
10), respectively. As shown in Fig. 4 A, application of the
dihydropyridine BayK8644 (0.5 mM), a selective opener of
VDCC, led to a [Ca21]i increase in a GFP-positive cell as-
sociated with [Ca21]i oscillations (n 5 2). Combined super-
fusion of BayK8644 and high K1 (140 mM) solution
evoked a sustained increase of [Ca21]i. Nisoldipine (0.5
mM), a selective blocker of VDCC, led to a decline of
[Ca21]i close to baseline levels (Fig. 4 A, n 5 8), indicating
the exclusive involvement of ICa. The [Ca21]i increase
evoked by coapplication of BayK8644 and high K1 solu-
tion was 252 6 37 nM (n 5 6) in 8-d-old cells. There was
no change of [Ca21]i in cells with no or only weak GFP flu-
orescence (Fig. 4 B, n 5 20).
In 187 cells, the correlation between GFP fluorescence
intensities and the functional expression of VDCC was in-
vestigated. As demonstrated in Fig. 4 C, a rise of [Ca21]i
upon superfusion with BayK8644/high K1 was observed as
early as 7 d, and at that time only in one cell. This cell did
not display a difference in the GFP fluorescence intensity
compared with nonresponding cells (Fig. 4 C). In the later
stages (8Ð11 d), there was a clear correlation between GFP
intensity and the expression of VDCC, seen by a rise in
[Ca21]i upon superfusion with BayK8644/high K1 solution.
On 9Ð11 d, almost all cells with bright GFP fluorescence
responded to BayK8644/high K1 with a large increase of
[Ca21]i (1052.9 6 223.8 nM, n 5 20). Thus, at this stage of
development the GFP expression was strongly correlated
with ICa expression.
The experiments using Ca21 imaging demonstrated that
ICa was already functionally expressed during the initial
steps of cardiomyogenesis. To investigate in more detail
the biophysical profile, current density, and the regulation
of ICa in cardiac precursor cells, we performed whole-cell
patch clamp experiments on GFP-positive cells. These
were identified using a fluorescence microscope. In con-
trol experiments, we found that ICa was, besides small am-
plitude K1 currents, the prominent ion channel detected at
this early stage of development. Since initial experiments
showed, that ICa was expressed at very low densities, 10 mM
Ca21 as charge carrier was used. ICa was evoked applying
depolarizing voltage steps from a holding potential of 280
mV to a test potential of 110 mV. The earliest time point
at which ICa could be detected was 7 d. As can be seen in
Fig. 5 A, the currentÐvoltage relationship of ICa in a 7-d-old
cardiac precursor cell proved to be similar to that of an
9-d-old cardiomyocyte (Fig. 5 B). The threshold of activa-
tion was close to 240 mV, and peak ICa was measured at
110 mV (Fig. 5, A and B). ICa was detected in 22.2% of
the GFP-positive 7-d-old cells, but at very low density
Figure 2. FACS¨ profiles of ES cells and EB-derived cells ex-
pressing GFP under control of the human cardiac a-actin pro-
moter (pCX-(a-act)-EGFP-NeoR). FACS¨ analysis was per-
formed on different stages of EB development as indicated in the
upper left corners. The M1 bar marks the range of GFP fluores-
cence. GFP fluorescence intensities of nontransfected ES cells
(wt, A) and pCX-(a-act)-EGFP-NeoRÐtransfected ES cells (B)
were similar and characterized by low fluorescence intensities.
ES cells carrying the cardiac pCX-(a-act)-EGFP-NeoR develop a
fluorescent peak of high intensity during differentiation of EBs
(7d and 12d). After appearance of spontaneously contracting car-
diomyocytes, a further enlargement to higher fluorescence inten-
sities was observed (12d).The Journal of Cell Biology, Volume 143, 1998 2050
(3.8 6 1.3 pA/pF, n 5 54) (Fig. 5, CÐE). The percentage of
GFP-positive cells expressing ICa increased dramatically
within the next 24 h and was close to 80% at 10 d (Fig. 5
D). GFP-negative cells did not express VDCC in 7Ð10-d-old
EBs (n 5 20; Fig. 5 C). The current was identified as car-
diac ICa on the basis of its fast activation kinetics, currentÐ
voltage relationship (Fig. 5), and sensitivity to nisoldipine
(2 mM, n 5 2) (Fig. 6 A). To show the blocking effect of ni-
Figure 3. Immunocytochemical pattern
of a-actin and a-actinin staining in sin-
gle ES cellÐderived cells expressing
GFP under control of the human car-
diac a-actin promoter. (A and B) Im-
munostaining with a-actin antibody of
a GFP-positive cell. This cell displayed
characteristic morphological features
for an early stage cardiomyocyte with
the typical round shape morphology
and the low cytoplasm/nucleus ratio.
(A) The GFP-derived fluorescence was
spread over the whole cell. (B) The
a-actin immunofluorescence was pri-
marily expressed in the perinuclear re-
gion. (C and D) Comparison of GFP
expression under control of the human
cardiac a-actin promoter and a-actinin
immunoreaction of a more elongated,
late-stage cardiomyocyte. (C) In this
more differentiated cardiomyocyte, the
GFP fluorescence was spread over the
entire cell. (D) The a-actinin immuno-
fluorescence displayed a typical cross
pattern, indicating sarcomeric organi-
zation in this cardiomyocyte. Bar, 10 mm.
Figure 4. Functional expression of VDCC determined with Ca21 imaging in single GFP-positive cells of different stages. Single ES cellÐ
derived cells were loaded with the membrane-permeant form of the Ca21 indicator fura-2. First, individual cells were tested for their
GFP fluorescence using 488-nm excitation light (1 s) and an FITC filter block. Then, the cytosolic Ca21 concentration [Ca21]i was moni-
tored using a fura-2 filter block and 340/380 excitation light. The recording chamber was subsequently perfused with BayK8644/high
K1Ðcontaining solution to depolarize the membrane potential and test for the functional expression of VDCC. (A) A GFP-positive cell,
with an oscillatory [Ca21]i increase upon application of the selective VDCC agonist BayK8644 (0.5 mM). Subsequent perfusion of
BayK8644 and high K1 (140 mM) leads to a sustained increase in [Ca21]i, which was blocked by the selective VDCC antagonist nisol-
dipine (0.5 mM). (B) In a GFP-negative cell, application of BayK8644/high K1 did not induce changes of [Ca21]i. (C) GFP fluorescence
intensities and the functional expression of VDCC proved strongly correlated. Cells derived from 6-d-old EBs had low GFP fluores-
cence and no changes in [Ca21]i upon BayK8644/high K1 perfusion. On 7 d, only one cell displayed a [Ca21]i increase upon BayK8644/
high K1 perfusion, but no difference in GFP fluorescence was detected. 8-d and older cells that expressed VDCC also displayed high
GFP fluorescence intensities.Kolossov et al. Functional Characteristics of Cardiac Precursor Cells 2051
soldipine more clearly, the mean current for peak ICa be-
fore and after addition of the drug is shown (Fig. 6 A, 1
and 2, dotted line) in the time course (Fig. 6 A, right). The
biophysical and pharmacological characteristics excluded
that functional T-type and/or the skeletal muscleÐspecific
slow-activating Ca21 current reported for ES cellÐderived
skeletal myocytes (Rohwedel et al., 1994) were expressed
in GFP-positive precursor cells.
Next, we investigated the regulation of ICa in these car-
diac precursor cells. Superfusion with forskolin (1 mM), a
selective activator of the adenylyl-cyclase, did not result in
an increase of ICa (Fig. 6 B) in 7-d-old cells, indicating that
the cAMP-dependent pathway was not yet functional. A
characteristic property of the L-type Ca21 channel is the
increase in current amplitude upon phosphorylation by PKA
(Osterrieder et al., 1982). Therefore, we tested whether ICa
could be stimulated by dialysis with the catalytic subunit of
PKA in 7-d-old cardiac precursor cells. The amplitude of
ICa measured after 5 min cell dialysis with the catalytic
subunit of PKA was normalized to the value obtained af-
ter 1 min. As seen in Fig. 6 D, four out of four cells tested
displayed an increase of peak ICa, (the average increase of
peak ICa amounts to 1.7-fold). This is also reflected in the
time course of peak ICa (Fig. 6 C, right; note the linear re-
gression superimposed on the time course). In control
cells, either stable ICa amplitudes or run down of ICa was
observed (n 5 5; Fig. 6 D).
Functional Ryanodine-sensitive Ca21 Stores
Are Detected Later than ICa in Most Early Stage 
Cardiomyocytes; IP3 Receptors and the
Sarco-/Endoplasmic Ca21-ATPase Are Found during 
All Differentiation Stages
For the investigation of functional ryanodine-sensitive
Ca21 stores, caffeine (10 mM) was applied on GFP-posi-
tive cells through a puffer pipette. Because of the close
correlation between GFP fluorescence intensity and VDCC
Figure 5. Patch clamp recordings of L-type Ca21
currents (ICa) in GFP-positive ES cellÐderived
cells (10 mM extracellular Ca21). For the record-
ing of the current-voltage relationship, cells were
voltage clamped in the whole-cell configuration
at a holding potential of 280 mV, and 50-ms de-
polarizing voltage steps were applied from 240
mV to 140 mV in 10-mV increment steps. The
currentÐvoltage relationship of 7-d (A) and 9-d
(B) cells was similar. The threshold for activation
was typically around 240 mV and peak currents
at 110 mV. The expression of ICa was investi-
gated in GFP-negative and -positive cells. (C) ICa
was detected only in GFP-positive cells. (C and
D) ICa was not detected before 7 d, and in the fol-
lowing days a clear increase in the peak current
amplitude was observed. (D) Correlation be-
tween differentiation stage and number of GFP-
positive cells expressing ICa. (E) Peak ICa densi-
ties increased with increasing age of EB-derived
cells (same cell population as in C).The Journal of Cell Biology, Volume 143, 1998 2052
expression (Fig. 4 C), only cells with GFP intensities larger
than 60 counts were chosen for these experiments. As
shown in Fig. 7, A and C, most of the GFP-positive cells
showed no detectable caffeine responses at 8/9 d. Within
the following 2 d, there was a clear increase in the percent-
age of responding cells in these early, GFP-expressing car-
diomyocytes. As depicted in Fig. 7 B, application of caf-
feine leads to a rise of [Ca21]i before (234 6 36 nM) and
after superfusion with high K1/BayK8644 solution
(1,993  6  684 nM, n 5 5, 10/11d). Most of the GFP-positive
cells at 9 d express functional VDCC but not ryanodine-
sensitive Ca21 stores, whereas 24 h later most of the GFP-
positive cells coexpress both (Fig. 7 C).
We tested also for the expression of IP3-sensitive Ca21
stores by dialyzing voltage-clamped ES cells and EB-
derived cardiomyocytes of different stages with IP3 (100
mM) and fura-2 (125 mM) (Fig. 8, right panels). To avoid
the activation of Ca21 influx pathway(s) (holding potential
280 mV), the cells were superfused with nominally Ca21-
free solution. Cells of various differentiation stages (ES
cells, 5, 7, and 9 d, n 5 4 for each differentiation stage)
were examined and responded to IP3 perfusion with an in-
crease of the 360/390-nm ratio 10Ð20 s after establishment
of the whole-cell configuration (Fig. 8). There was no sig-
nificant difference in the response between the various
stages of development or between GFP-positive and -neg-
ative cells (data not shown). Cell dialysis with fura-2 but
without IP3 in the patch pipette resulted in all cells tested
(n 5 5) in a decrease of the 360/390-nm ratio (Fig. 8, right
panels, insets), probably because of a lowering of resting
[Ca21]i caused by the high concentration of exogenous
buffers added to the cell (Neher and Augustine, 1992).
Application of the selective Ca21-ATPase inhibitor Tg
(1 mM) (Thastrup et al., 1990) resulted in GFP-positive as
well as -negative cells of all differentiation stages tested
(0Ð9 d) in a fast increase of [Ca21]i (Fig. 8, left panels). In
ES cells, this increase consisted of a transient and a gado-
linium (Gd31)-sensitive sustained phase (Fig. 8 A, left; n 5
Figure 6. Pharmacology and modulation of ICa in
7-d-old GFP-positive cells. 7-d-old GFP-positive
cells were voltage clamped at 280 mV, and 50-
ms depolarizing pulses to 110 mV were applied
at a frequency of 0.2 Hz (10 mM extracellular
Ca21). (A) Application of the VDCC selective
antagonist nisoldipine (1 mM) blocked ICa, (cur-
rent traces, left), confirming that the inward cur-
rent was ICa. The time course (right) demon-
strated that ICa was blocked upon nisoldipine
application. Every single point in the time course
represents the peak ICa evoked by a depolarizing
voltage step, and the numbers indicate the volt-
age steps displayed on the left side. The two hor-
izontal lines represent the mean current level
taken before and after addition of nisoldipine.
Initially, the mean current was stable, and after
nisoldipine addition, ICa was completely blocked.
(B) Superfusion with the adenylyl-cyclase activa-
tor forskolin (1 mM) did not increase the ICa am-
plitude. The mean current level in the time
course remains unaltered, confirming that for-
skolin was without effect. (C) Dialysis with the
catalytic subunit of PKA (7 mM) led to an in-
crease of ICa. This can also be seen from the lin-
ear regression displayed in the time course. (D)
A quantitative comparison of the development
of ICa in 7-d-old GFP-positive cells in the absence
(gray bar) and in the presence of the catalytic
subunit of PKA (black bar) is shown. The rela-
tionship of the peak current after 5 min and after
1 min is shown. In the control group, a reduction
of ICa over time, probably because current run
down, was noted. In contrast, ICa, increased in
the presence of the catalytic subunit of PKA, in-
dicating that at this early stage the VDCC can al-
ready be phosphorylated.Kolossov et al. Functional Characteristics of Cardiac Precursor Cells 2053
5), pointing towards activation of a Ca21 influx pathway.
In contrast, the Tg-induced rise of [Ca21]i in cardiac pre-
cursor cells (Fig. 8 B, left; n 5 5) was only transient.
Discussion
The main goal of the present study was the functional
characterization of cardiomyocytes before the initiation of
contraction. In particular, we investigated the functional
expression of cellular components playing a key role for
cardiac function, i.e., L-type Ca21 channels, Ca21 release
sites, and Ca21 pumps.
Since the cardiac precursor cells still lack the character-
istic cross striation and spontaneous contractions, we have
used the in vivo fluorescent reporter gene GFP for the
identification of these early cardiomyocytes. For this pur-
pose, we have used the ES cell system for the differentia-
tion of cardiomyocytes (Doetschman et al., 1985; Wobus
et al., 1991; Westfall et al., 1997) and established stably
transfected ES cell lines, where the GFP expression was
under control of the cardiac-specific human cardiac a-actin
promoter (Minty and Kedes, 1986; Pari et al., 1991). The
stable GFP expression has proven particularly helpful for
our investigation since it allowed the identification of
GFP-positive cells even very early during development.
As reported for transgenic mice, where (E)GFP expres-
sion was under control of the ubiquitous b-actin promoter
(Ikawa et al., 1995; Okabe et al., 1997), (E)GFP did not in-
terfere on ES cellÐderived cardiomyocytes. The a-actin
promoter was chosen because transcripts for cardiac a-actin
were detected as early as on E7.5 in the developing murine
heart (Sassoon et al., 1988; Lyons et al., 1991). Accord-
ingly, the activity of the LacZ reporter gene under control
of the (2440 to 16) segment of the human cardiac a-actin
promoter has been shown to be cardiac specific and
switched on before the onset of spontaneous contractions
in EBs (Metzger et al., 1996).
The pattern of GFP fluorescence as well as the overlap
between GFP expression and spontaneous contractions in-
dicated the specificity, which was further confirmed by im-
munocytochemistry. It is well known from the literature
that cardiac a-actin and skeletal a-actin are coexpressed in
both cardiac and skeletal muscle during embryonic develop-
ment (Sassoon et al., 1988; Alonso et al., 1990; Lyons et
al., 1991). However, the GFP-positive precursor cells in
our experiments did clearly not comprise skeletal muscle
cells for the following reasons: (a) the Ca21 currents deter-
mined in these cells displayed fast activation kinetics,
which clearly differed from the slow activation kinetics
typical for the skeletal Ca21 current. Moreover, T-type
Ca21 currents were excluded because of the currentÐvolt-
age relationship, pharmacology, and PKA-dependent phos-
phorylation. (b) GFP-positive cells of later developmental
stages displayed electrophysiological as well as morpho-
logical characteristics typical for cardiomyocytes. (c) All
GFP-positive precursor cells showed immunostaining for
ANP, which is known to be expressed early during cardio-
myogenesis, but not in skeletal myocytes (Miller-Hance et
al., 1993; Hescheler et al., 1997). Because of the funda-
mental role of VDCC and Ca21 storage organelles for car-
diac function, their functional expression was investigated
in these early GFP-positive cardiomyocytes. Many studies
Figure 7. Temporal correlation between the functional expression of VDCC and ryanodine-sensitive Ca21 stores using Ca21 imaging.
ES cellÐderived cells of different developmental stages were first tested for their GFP fluorescence intensity and subsequently for the
functional expression of VDCC with superfusion of high K1/BayK8644 or for ryanodine-sensitive stores with application of caffeine (10
mM) through a puffer pipette. (A) Representative experiment of a GFP-positive 8-d-old cell, which does not respond to caffeine (ar-
rows indicate start of application, duration 7 s) but displays a [Ca21]i increase upon high K1/BayK8644 perfusion. (B) An 11-d-old GFP-
positive cell responds to caffeine (arrows) and high K1/BayK8644 with a large transient and a smaller, more sustained rise of [Ca21]i, re-
spectively, indicating the functional expression of ryanodine-sensitive Ca21 stores and VDCC. The depolarization-induced [Ca21]i rise is
larger and faster inactivating than in 8-d-old cells. (C) The correlation between caffeine and VDCC expression, tested in different cells
during various differentiation stages. For this analysis, only cells with GFP fluorescence intensities (60 counts were selected). In most of
the early stage cardiomyocytes the functional expression of VDCC occurs before ryanodine-sensitive Ca21 stores.The Journal of Cell Biology, Volume 143, 1998 2054
have been performed on later embryonic and neonatal
mammalian cardiomyocytes, where expression and bio-
physical characteristics of VDCC and Ca21 handling pro-
teins differed relatively little from terminally differenti-
ated cardiomyocytes (Josephson and Sperelakis, 1989;
Masuda and Sperelakis, 1993; Davies et al., 1996; Takano
and Noma, 1997). However, almost no functional data are
available on very early mammalian cardiomyocytes before
E11. Therefore, the ES cell differentiation system in com-
bination with cardiac a-actin promoterÐdriven GFP ex-
pression allowed the identification and functional charac-
terization of cardiomyocytes before beating. Patch clamp
studies demonstrated the expression of L-type Ca21 chan-
nels at very low density 1 d after plating (7 d). In contrast
to embryonic chicken cardiomyocytes, where a decrease
of ICa density during development was reported (Tohse
et al., 1992b), in the present preparation, a steep increase
in ICa density from 7- to 10-d-old cardiomyocytes was
observed. The current was identified as VDCC based on
its biophysical and pharmacological characteristics, which
were similar to VDCC of adult cardiomyocytes. In line
with our previous findings on early stage ES cellÐderived
cardiomyocytes (Maltsev et al., 1994), ICa was blocked
completely by nisoldipine making an involvement of addi-
tional Ca21 channel isoforms, i.e., T-type Ca21 channels
unlikely. Already at this early stage ICa was stimulated by
the catalytic subunit of PKA as described for terminally
differentiated cardiomyocytes (Osterrieder et al., 1982;
Hartzell and Fischmeister, 1986; Kameyama et al., 1986a).
These data provide strong evidence for similar structural
properties of the Ca21 channel protein, at least in regard to
the phosphorylation sites at this very early stage of devel-
opment. Similar to a recent report by An et al. (1996) for
E11Ð13 murine cardiomyocytes, the ICa amplitude was not
increased upon application of forskolin, a stimulator of
adenylyl-cyclase, in the ES cellÐderived cardiac precursor
cells. An et al. suggested a deficiency of the PKA holoen-
zyme. Because phosphodiesterases (Fischmeister and Hartz-
ell, 1990) and phosphatases (Kameyama et al., 1986b;
Wiechen et al., 1995) play an important role in cAMP
breakdown and L-type Ca21 channel dephosphorylation,
respectively, future studies have to clarify whether they
are already functional in cardiac precursor cells and in-
volved in the lack of the forskolin response. The functional
expression of the Ca21-ATPase and IP3 receptor stores
was proven by a rise in [Ca21]i upon application of Tg and
IP3, respectively, during all stages of development. The ex-
periments using Tg confirmed at a functional level previ-
ous findings, using in situ hybridization and Northern blot
analysis in rat (Moorman et al., 1995) as well as murine
embryos/EBs (Ganim et al., 1992), that the Ca21-ATPase
(SERCA2) is already expressed very early during cardiac
development. Which SERCA isoform/s is/are present at
the ES cell stage is currently not known. In contrast to ter-
minally differentiated ventricular cardiomyocytes in which
Tg did not induce changes of [Ca21]i (Gomez et al., 1996;
Song et al., 1997), it evoked a transient [Ca21]i increase in
early stage cardiomyocytes. This difference may point to a
low activity of the Na1-Ca21 exchanger and/or the domi-
nant role of the sarcoplasmic Ca21-ATPase for Ca21 ho-
meostasis at this early developmental stage. Most notably,
the functional expression of ryanodine-sensitive Ca21
stores was delayed in comparison to the expression of ICa
in the majority of cells tested. This may explain why oscil-
Figure 8. Functional expression of the sarcoplas-
mic Ca21-ATPase and IP3-sensitive Ca21 stores
in ES cells and ES cellÐderived cardiac precursor
cells. The expression of the sarcoplasmic Ca21-
ATPase was investigated by addition of the selec-
tive antagonist Tg (1 mM) (left panels). (A) Tg
evoked a sustained increase of [Ca21]i in ES cells,
indicating activation of a capacitative Ca21 influx
pathway. This was confirmed by application of
Gd31 (1 mM), which resulted in a fast decline of
elevated [Ca21]i to control levels. (B) In con-
trast, application of Tg in a cardiac precursor
cell (7 d) resulted in a transient rise of [Ca21]i.
The expression of IP3-sensitive Ca21 stores was
tested by intracellular dialysis of ES cellÐderived
cells during different stages of development with
IP3 (100 mM) and the Ca21 indicator fura-2
(125 M) through patch-pipette (right panels).
Changes in [Ca21]i were monitored using mea-
surements of the 360/390 ratio. Establishment
of the classic whole-cell configuration (arrow)
evoked in ES cells (A) and 7-d-old cardiomyo-
cytes (B) a fast increase of the 360/390 ratio be-
cause of an increase of [Ca21]i, indicating the
functional expression of IP3-sensitive stores. In
control experiments, omission of IP3 from the pi-
pette solution evoked a decrease of the 360/390
ratio (insets, identical calibration as for IP3 exper-
iments).Kolossov et al. Functional Characteristics of Cardiac Precursor Cells 2055
lations in membrane potential are registered earlier than
contractions in chick (Fujii et al., 1981) and rat (Hirota et
al., 1985) embryonic cardiomyocytes, despite the presence
of contractile proteins. This could be due to the lack of
CICR, the fundamental process responsible for excita-
tionÐcontraction coupling (Fabiato, 1985; Barcenas-Ruiz
and Wier, 1987; du Bell and Houser, 1987; Nabauer et al.,
1989). In the literature, electromechanical coupling in the
fetal heart (late embryonic stage) is suggested to be largely
dependent on transsarcolemmal Ca21 influx, rather than
Ca21 released from the SR (Nayler and Fassold, 1977; Ma-
hony and Jones, 1986; Klitzner and Friedman, 1989; Chin
et al., 1990). In addition, the SR was found to be morpho-
logically smaller in neonatal ventricular cardiomyocytes
(Olivetti et al., 1980), and the number of ryanodine recep-
tors in fetal rat ventricular cardiomyocytes (E22) was re-
duced as compared with adult rat ventricular cardiomyo-
cytes (Ramesh et al., 1995). Nevertheless, Su and Chang
(1993) report caffeine-induced contractions in fetal hearts.
Accordingly, a spatial coassociation between ryanodine
receptors and VDCC has been reported for chick cardio-
myocytes early during development (Sun et al., 1995;
Flucher and Franzini-Armstrong, 1996). Recently, embry-
onic lethality between E10.5Ð11.5 of mice carrying a gene
inactivation of the ryanodine 2 receptor was described
(Takeshima et al., 1998). While the hearts of mutant mice
started to spontaneously contract at E9.5, severe morpho-
logical changes of the SR and the mitochondria were de-
tected. The authors suggest that Ry-2 may not be required
for excitationÐcontraction coupling at this early embryonic
stage but play a crucial role for Ca21 homeostasis. Our
data fit nicely in since we demonstrate herewith functional
ryanodine-sensitive Ca21 stores in early stage cardiomyo-
cytes, and we provide at least indirect evidence for a role
of ryanodine-sensitive Ca21 receptors/stores for the estab-
lishment of contractile activity.
Therefore, we report to the best of our knowledge for
the first time the functional characterization of cardio-
myocytes before the beginning of spontaneous contrac-
tions. In these cardiac precursor cells, the VDCC are al-
ready functionally expressed and can be stimulated via
protein kinase AÐdependent phosphorylation. At this stage,
IP3 stores as well as sarcoplasmic Ca21-ATPases are al-
ready functional, while caffeine-sensitive ryanodine re-
ceptors/stores are not yet expressed. Interestingly, even
though ryanodine stores may not play such an important
role in excitationÐcontraction coupling at this early stage,
in our system their functional expression coincides with
the initiation of contractions. In the future, it will be inter-
esting to address the role of VDCC as well as of ryanodine
receptors for cardiomyogenesis by using selective pharma-
cological blockers during different stages of ES cellÐderived
cardiomyogenesis.
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